🔗 Visit the ClinicalTrials.gov page for NCT01348516
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects. | Drug Des Devel Ther | 2014 | 0.76 |